Joseph Roscoe
Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Nausea | 28 | 1998 | 34 |
Why?
|
Vomiting | 16 | 1998 | 45 |
Why?
|
Antineoplastic Agents | 24 | 1998 | 190 |
Why?
|
Neoplasms | 28 | 1998 | 239 |
Why?
|
Acupressure | 5 | 2002 | 8 |
Why?
|
Fatigue | 15 | 2001 | 48 |
Why?
|
Breast Neoplasms | 17 | 1986 | 185 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 10 | 1986 | 121 |
Why?
|
Acupuncture Therapy | 4 | 2002 | 8 |
Why?
|
Doxorubicin | 7 | 2003 | 60 |
Why?
|
Radiotherapy | 5 | 2002 | 73 |
Why?
|
Vomiting, Anticipatory | 5 | 1998 | 4 |
Why?
|
Aged | 33 | 1989 | 988 |
Why?
|
Middle Aged | 39 | 1986 | 1161 |
Why?
|
Depression | 5 | 2001 | 118 |
Why?
|
Attitude | 2 | 2000 | 54 |
Why?
|
Cisplatin | 3 | 2000 | 43 |
Why?
|
Antiemetics | 9 | 1998 | 15 |
Why?
|
Adult | 31 | 1986 | 1317 |
Why?
|
Female | 42 | 1986 | 1643 |
Why?
|
Carboplatin | 2 | 2003 | 16 |
Why?
|
Quality of Life | 12 | 1998 | 188 |
Why?
|
Humans | 59 | 1986 | 1856 |
Why?
|
Cyclohexanecarboxylic Acids | 3 | 2003 | 24 |
Why?
|
Amines | 3 | 2003 | 39 |
Why?
|
Wrist | 3 | 2002 | 27 |
Why?
|
gamma-Aminobutyric Acid | 3 | 2003 | 58 |
Why?
|
Paroxetine | 2 | 2003 | 6 |
Why?
|
Sleep Disorders | 3 | 2002 | 32 |
Why?
|
Hot Flashes | 2 | 2004 | 16 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2007 | 11 |
Why?
|
Acetic Acids | 2 | 2003 | 31 |
Why?
|
Psychophysiology | 1 | 2006 | 15 |
Why?
|
Community Health Centers | 2 | 2000 | 20 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2005 | 6 |
Why?
|
Therapeutic Touch | 1 | 2005 | 3 |
Why?
|
Patient Education as Topic | 5 | 2000 | 128 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2005 | 13 |
Why?
|
Aged, 80 and over | 16 | 1989 | 599 |
Why?
|
Behavior | 1 | 2004 | 36 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2004 | 8 |
Why?
|
Treatment Outcome | 13 | 1998 | 661 |
Why?
|
Radiation Injuries | 1 | 2005 | 63 |
Why?
|
Physical Stimulation | 1 | 2003 | 28 |
Why?
|
Academic Medical Centers | 2 | 2003 | 65 |
Why?
|
Tamoxifen | 1 | 2004 | 38 |
Why?
|
Male | 28 | 1989 | 1553 |
Why?
|
Electroacupuncture | 1 | 2002 | 2 |
Why?
|
Benzhydryl Compounds | 3 | 2005 | 9 |
Why?
|
Outcome Assessment (Health Care) | 1 | 2003 | 163 |
Why?
|
Serotonin Antagonists | 3 | 1998 | 9 |
Why?
|
Continental Population Groups | 2 | 1997 | 85 |
Why?
|
Questionnaires | 8 | 2000 | 360 |
Why?
|
Complementary Therapies | 2 | 2006 | 23 |
Why?
|
Prochlorperazine | 2 | 2005 | 5 |
Why?
|
Peritoneum | 1 | 1997 | 14 |
Why?
|
Kidney Failure, Chronic | 2 | 1997 | 57 |
Why?
|
Peritoneal Dialysis | 1 | 1997 | 11 |
Why?
|
Urea | 1 | 1997 | 31 |
Why?
|
Adaptation, Psychological | 2 | 2006 | 110 |
Why?
|
Severity of Illness Index | 5 | 2000 | 358 |
Why?
|
Perception | 3 | 2004 | 49 |
Why?
|
Patient Satisfaction | 3 | 2004 | 120 |
Why?
|
Behavior Therapy | 3 | 1998 | 51 |
Why?
|
Ondansetron | 2 | 1998 | 6 |
Why?
|
Risk Factors | 3 | 2000 | 555 |
Why?
|
Relaxation Therapy | 2 | 2007 | 12 |
Why?
|
Age Factors | 4 | 2004 | 480 |
Why?
|
Activities of Daily Living | 2 | 2001 | 122 |
Why?
|
Pain | 2 | 2006 | 191 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2000 | 145 |
Why?
|
Psychology, Medical | 1 | 2011 | 2 |
Why?
|
Double-Blind Method | 4 | 2003 | 274 |
Why?
|
Cyclophosphamide | 3 | 2003 | 82 |
Why?
|
Self Efficacy | 1 | 2011 | 27 |
Why?
|
Suggestion | 1 | 2010 | 7 |
Why?
|
Receptors, Serotonin, 5-HT3 | 3 | 1998 | 2 |
Why?
|
Dentate Gyrus | 1 | 2010 | 20 |
Why?
|
Central Nervous System Stimulants | 1 | 2010 | 32 |
Why?
|
Information Seeking Behavior | 1 | 2009 | 2 |
Why?
|
Hypnosis | 2 | 2006 | 9 |
Why?
|
Clinical Trials as Topic | 4 | 1989 | 251 |
Why?
|
Pilot Projects | 3 | 2004 | 264 |
Why?
|
Information Services | 1 | 2009 | 21 |
Why?
|
Community Health Services | 2 | 2006 | 60 |
Why?
|
Blood-Brain Barrier | 1 | 2010 | 63 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 64 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2009 | 20 |
Why?
|
Placebos | 2 | 2005 | 110 |
Why?
|
Adolescent | 6 | 1989 | 891 |
Why?
|
Young Adult | 2 | 2009 | 380 |
Why?
|
Awareness | 1 | 2008 | 25 |
Why?
|
Pregnancy | 2 | 2002 | 455 |
Why?
|
Sickness Impact Profile | 1 | 2007 | 26 |
Why?
|
Survivors | 2 | 2004 | 45 |
Why?
|
Stress, Psychological | 1 | 2011 | 117 |
Why?
|
Cognition | 1 | 2009 | 97 |
Why?
|
Incidence | 1 | 2009 | 336 |
Why?
|
Placebo Effect | 1 | 2006 | 26 |
Why?
|
Serotonin | 2 | 2001 | 44 |
Why?
|
Acupuncture Points | 1 | 2005 | 1 |
Why?
|
Administration, Oral | 2 | 2003 | 170 |
Why?
|
Models, Psychological | 1 | 2006 | 44 |
Why?
|
Menopause | 1 | 2005 | 27 |
Why?
|
Choice Behavior | 1 | 2006 | 34 |
Why?
|
Motion Sickness | 1 | 2004 | 3 |
Why?
|
Sex Factors | 3 | 1997 | 284 |
Why?
|
Serotonin 5-HT3 Receptor Antagonists | 1 | 2004 | 3 |
Why?
|
Tai Ji | 1 | 2004 | 8 |
Why?
|
Exercise | 1 | 2006 | 82 |
Why?
|
Chronic Disease | 1 | 2007 | 267 |
Why?
|
Decision Making | 1 | 2006 | 130 |
Why?
|
Serotonin Uptake Inhibitors | 1 | 2003 | 19 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 219 |
Why?
|
Demography | 3 | 2006 | 87 |
Why?
|
Receptors, Serotonin | 2 | 1998 | 6 |
Why?
|
Pregnancy Complications | 1 | 2004 | 98 |
Why?
|
New England | 1 | 2002 | 17 |
Why?
|
Cross-Over Studies | 1 | 2002 | 82 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 1 | 2001 | 5 |
Why?
|
Health Surveys | 3 | 2004 | 103 |
Why?
|
Affect | 1 | 2001 | 55 |
Why?
|
Patients | 1 | 2001 | 37 |
Why?
|
Circadian Rhythm | 1 | 2001 | 50 |
Why?
|
Reference Values | 1 | 2002 | 278 |
Why?
|
Multivariate Analysis | 1 | 2002 | 225 |
Why?
|
Ovarian Neoplasms | 1 | 2000 | 64 |
Why?
|
Self-Assessment | 2 | 2006 | 35 |
Why?
|
Granisetron | 1 | 1998 | 2 |
Why?
|
Regression Analysis | 1 | 2000 | 256 |
Why?
|
Analysis of Variance | 3 | 2003 | 339 |
Why?
|
Diabetic Nephropathies | 1 | 1997 | 18 |
Why?
|
Permeability | 1 | 1997 | 52 |
Why?
|
Follow-Up Studies | 4 | 1989 | 553 |
Why?
|
Patient Acceptance of Health Care | 2 | 2008 | 70 |
Why?
|
Asian Continental Ancestry Group | 1 | 1997 | 23 |
Why?
|
Carcinoma | 1 | 1999 | 109 |
Why?
|
Weight Loss | 2 | 2004 | 51 |
Why?
|
Biological Transport | 1 | 1997 | 129 |
Why?
|
African Continental Ancestry Group | 1 | 1997 | 80 |
Why?
|
Palliative Care | 1 | 1998 | 65 |
Why?
|
Ethnic Groups | 1 | 1997 | 95 |
Why?
|
Longitudinal Studies | 2 | 2005 | 195 |
Why?
|
Social Support | 2 | 2004 | 111 |
Why?
|
Prostatic Neoplasms | 1 | 2002 | 120 |
Why?
|
Physician-Patient Relations | 3 | 2000 | 111 |
Why?
|
European Continental Ancestry Group | 1 | 1997 | 117 |
Why?
|
United States | 3 | 2006 | 604 |
Why?
|
Time Factors | 4 | 1986 | 896 |
Why?
|
Attitude to Health | 2 | 2006 | 106 |
Why?
|
Prevalence | 2 | 2002 | 281 |
Why?
|
New York | 2 | 2006 | 422 |
Why?
|
Indiana | 1 | 2011 | 4 |
Why?
|
Massage | 1 | 2011 | 9 |
Why?
|
Factor Analysis, Statistical | 1 | 2011 | 45 |
Why?
|
Neurogenesis | 1 | 2010 | 18 |
Why?
|
Bromodeoxyuridine | 1 | 2010 | 47 |
Why?
|
Energy Metabolism | 1 | 2011 | 80 |
Why?
|
Fluorouracil | 1 | 2010 | 49 |
Why?
|
Psychometrics | 1 | 2011 | 97 |
Why?
|
Paclitaxel | 1 | 2010 | 37 |
Why?
|
Outpatients | 1 | 2009 | 29 |
Why?
|
Glomerulonephritis, Membranous | 1 | 1989 | 2 |
Why?
|
Confidence Intervals | 1 | 2009 | 104 |
Why?
|
Memory | 1 | 2009 | 61 |
Why?
|
Needs Assessment | 1 | 2009 | 67 |
Why?
|
Health Services Needs and Demand | 1 | 2009 | 66 |
Why?
|
Health Behavior | 1 | 2009 | 61 |
Why?
|
Odds Ratio | 1 | 2009 | 157 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2007 | 10 |
Why?
|
Prednisone | 1 | 1989 | 80 |
Why?
|
Attention | 1 | 2009 | 64 |
Why?
|
Reproducibility of Results | 1 | 2011 | 391 |
Why?
|
Quality Indicators, Health Care | 1 | 2007 | 34 |
Why?
|
Cognitive Therapy | 1 | 2007 | 26 |
Why?
|
Sulfinpyrazone | 1 | 1986 | 2 |
Why?
|
Argininosuccinic Acid | 1 | 1986 | 2 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2006 | 45 |
Why?
|
Mitomycins | 1 | 1986 | 13 |
Why?
|
Drug Administration Schedule | 2 | 1989 | 191 |
Why?
|
Plasmapheresis | 1 | 1986 | 20 |
Why?
|
Cell Proliferation | 1 | 2010 | 227 |
Why?
|
Cancer Care Facilities | 1 | 2006 | 14 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2006 | 49 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2006 | 55 |
Why?
|
Arginine | 1 | 1986 | 57 |
Why?
|
Program Evaluation | 1 | 2006 | 115 |
Why?
|
Electric Stimulation Therapy | 1 | 2005 | 16 |
Why?
|
Radiation Dosage | 1 | 2005 | 65 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 318 |
Why?
|
Alopecia | 1 | 2004 | 16 |
Why?
|
Dexamethasone | 1 | 2005 | 109 |
Why?
|
Antidepressive Agents | 1 | 2005 | 46 |
Why?
|
Psychotherapy | 1 | 2005 | 46 |
Why?
|
Educational Status | 1 | 2004 | 99 |
Why?
|
Acute Disease | 1 | 2005 | 271 |
Why?
|
Self Concept | 1 | 2004 | 65 |
Why?
|
Blood Platelets | 1 | 1986 | 67 |
Why?
|
Glucocorticoids | 1 | 2005 | 107 |
Why?
|
Communication | 1 | 2006 | 116 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2005 | 176 |
Why?
|
Chi-Square Distribution | 1 | 2003 | 179 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2003 | 99 |
Why?
|
Neurons | 1 | 2010 | 195 |
Why?
|
Hospitals, Chronic Disease | 1 | 2001 | 3 |
Why?
|
Ontario | 1 | 2001 | 12 |
Why?
|
Peritonitis | 1 | 2001 | 28 |
Why?
|
Behavioral Medicine | 1 | 2001 | 9 |
Why?
|
Infection | 1 | 2001 | 57 |
Why?
|
Vagus Nerve | 1 | 2001 | 25 |
Why?
|
Health Status Indicators | 1 | 2002 | 66 |
Why?
|
Pituitary-Adrenal System | 1 | 2001 | 19 |
Why?
|
Autonomic Nervous System | 1 | 2001 | 41 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2001 | 25 |
Why?
|
Catheters, Indwelling | 1 | 2001 | 46 |
Why?
|
Anemia | 1 | 2001 | 60 |
Why?
|
Sampling Studies | 1 | 2000 | 40 |
Why?
|
Professional-Patient Relations | 1 | 2000 | 34 |
Why?
|
Breast Neoplasms, Male | 1 | 1999 | 6 |
Why?
|
Informed Consent | 1 | 2000 | 62 |
Why?
|
Adenosine Triphosphate | 1 | 2001 | 121 |
Why?
|
Data Collection | 1 | 2000 | 137 |
Why?
|
Mice | 1 | 2010 | 623 |
Why?
|
Emetics | 1 | 1998 | 4 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2001 | 431 |
Why?
|
Creatinine | 2 | 1986 | 69 |
Why?
|
Cytokines | 1 | 2001 | 207 |
Why?
|
Sensitivity and Specificity | 1 | 2000 | 427 |
Why?
|
Retrospective Studies | 1 | 2001 | 653 |
Why?
|
Animals | 1 | 2010 | 1031 |
Why?
|
Proteinuria | 1 | 1989 | 20 |
Why?
|
Random Allocation | 1 | 1989 | 160 |
Why?
|
Tablets, Enteric-Coated | 1 | 1986 | 2 |
Why?
|
Dipyridamole | 1 | 1986 | 7 |
Why?
|
Mitomycin | 1 | 1986 | 13 |
Why?
|
Prospective Studies | 1 | 1989 | 545 |
Why?
|
Adenocarcinoma | 1 | 1986 | 167 |
Why?
|
